<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Low molecular weight heparin for prevention of microvascular occlusion in digital replantation - Lin, PT - 2020 | Cochrane Library</title> <meta content="Low molecular weight heparin for prevention of microvascular occlusion in digital replantation - Lin, PT - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009894.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Low molecular weight heparin for prevention of microvascular occlusion in digital replantation - Lin, PT - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009894.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009894.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Low molecular weight heparin for prevention of microvascular occlusion in digital replantation" name="citation_title"/> <meta content="Pei‐Tzu Lin" name="citation_author"/> <meta content="Shu‐Hui Wang" name="citation_author"/> <meta content="Ching‐Chi Chi" name="citation_author"/> <meta content="chingchi@cgmh.org.tw" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD009894.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/04/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009894.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009894.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009894.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [adverse effects, *therapeutic use]; Blood Coagulation Disorders [chemically induced]; Fingers [blood supply, *transplantation]; Heparin [therapeutic use]; Heparin, Low‐Molecular‐Weight [adverse effects, *therapeutic use]; Microvessels [*surgery]; Peripheral Arterial Disease [epidemiology]; Postoperative Hemorrhage [chemically induced]; Randomized Controlled Trials as Topic; Replantation [*adverse effects]; Venous Insufficiency [epidemiology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009894.pub3&amp;doi=10.1002/14651858.CD009894.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="9mpoajSI";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009894\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009894\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa","fr","ms","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009894.pub3",title:"Low molecular weight heparin for prevention of microvascular occlusion in digital replantation",firstPublishedDate:"Apr 17, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009894.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009894.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009894.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009894.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009894.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009894.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009894.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009894.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009894.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009894.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1860 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009894.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-sec-0104"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-sec-0096"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/appendices#CD009894-sec-0109"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/table_n/CD009894StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/table_n/CD009894StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Low molecular weight heparin for prevention of microvascular occlusion in digital replantation </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/information#CD009894-cr-0002">Pei‐Tzu Lin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/information#CD009894-cr-0003">Shu‐Hui Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009894.pub3/information#CD009894-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Ching‐Chi Chi</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/information/en#CD009894-sec-0116">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 April 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009894.pub3">https://doi.org/10.1002/14651858.CD009894.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009894-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009894-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009894-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009894-abs-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009894-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009894-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009894-abs-0001" lang="en"> <section id="CD009894-sec-0001"> <h3 class="title" id="CD009894-sec-0001">Background</h3> <p>The success of digital replantation is highly dependent on the patency of the repaired vessels after microvascular anastomosis. Antithrombotic agents are frequently used for preventing vascular occlusion. Low molecular weight heparin (LMWH) has been reported to be as effective as unfractionated heparin (UFH) in peripheral vascular surgery, but with fewer adverse effects. Its benefit in microvascular surgery such as digital replantation is unclear. This is an update of the review first published in 2013. </p> </section> <section id="CD009894-sec-0002"> <h3 class="title" id="CD009894-sec-0002">Objectives</h3> <p>To assess if treatment with subcutaneous LMWH improves the salvage rate of the digits in patients with digital replantation after traumatic amputation. </p> </section> <section id="CD009894-sec-0003"> <h3 class="title" id="CD009894-sec-0003">Search methods</h3> <p>The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase, AMED and CINAHL databases, and the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers, to 17 March 2020. The authors searched PubMed, China National Knowledge Infrastructure (CNKI) and Chinese Electronic Periodical Services (CEPS) on 17 March 2020 and sought additional trials from reference lists of relevant publications. </p> </section> <section id="CD009894-sec-0004"> <h3 class="title" id="CD009894-sec-0004">Selection criteria</h3> <p>We included randomised or quasi‐randomised controlled trials comparing treatment with LMWH versus any other treatment in participants who received digital replantation following traumatic digital amputation. </p> </section> <section id="CD009894-sec-0005"> <h3 class="title" id="CD009894-sec-0005">Data collection and analysis</h3> <p>Two review authors (PL, CC) independently extracted data and assessed the risk of bias of the included trials using Cochrane's 'Risk of bias' tool. Disagreements were resolved by discussion. We assessed the certainty of evidence using the GRADE approach. </p> </section> <section id="CD009894-sec-0006"> <h3 class="title" id="CD009894-sec-0006">Main results</h3> <p>We included two new randomised trials in this update, bringing the total number of included trials to four. They included a total of 258 participants, with at least 273 digits, from hospitals in China. Three studies compared LMWH versus UFH, and one compared LMWH versus no LMWH. The mean age of participants ranged from 24.5 to 37.6 years. In the studies reporting the sex of participants, there were a total of 145 men and 59 women. The certainty of the evidence was downgraded to low or very low because all studies were at high risk of performance or reporting bias (or both) and there was imprecision in the results due to the small numbers of participants. </p> <p>The three studies comparing LMWH versus UFH reported the success rate of replantation using different units of analysis (participant or digit), so we were unable to combine data from all three studies (one study reported results for both participants and digits). No evidence of a benefit in success of replantation was seen in the LMWH group when compared with UFH, regardless of whether the outcomes were reported by number of participants (risk ratio (RR) 0.98, 95% confidence interval (CI) 0.87 to 1.10; 130 participants, 2 studies; very low‐certainty evidence); or by number of digits (RR 0.97, 95% CI 0.90 to 1.04; 200 digits, 2 studies; low‐certainty evidence). No studies reported the incidence of compromised microcirculation requiring surgical or non‐surgical therapy, or any systemic/other causes of microvascular insufficiency. There was no evidence of a clear difference between the LMWH and UFH groups in occurrence of arterial occlusion (RR 1.08, 95% CI 0.16 to 7.10; 54 participants, 1 study; very low‐certainty evidence) or venous occlusion (RR 0.81, 95% CI 0.20 to 3.27; 54 participants, 1 study; very low‐certainty evidence). Two studies reported adverse effects. The LMWH and UFH groups showed no evidence of a difference in wound bleeding (RR 0.53, 95% CI 0.23 to 1.23; 130 participants, 2 studies; low‐certainty evidence), haematuria (RR 0.43, 95% CI 0.09 to 2.11; 130 participants, 2 studies; very low‐certainty evidence), ecchymoses (RR 0.82, 95% CI 0.21 to 3.19; 130 participants, 2 studies; very low‐certainty evidence), epistaxis (RR 0.27, 95% CI 0.03 to 2.32; 130 participants, 2 studies; very low‐certainty evidence), gingival bleeding (RR 0.18, 95% CI 0.02 to 1.43; 130 participants, 2 studies; very low‐certainty evidence), and faecal occult blood (RR 0.27, 95% CI 0.03 to 2.31; 130 participants, 2 studies; very low‐certainty evidence). We could not pool data on coagulation abnormalities as varying definitions and tests were used in the three studies. </p> <p>One study compared LMWH versus no LMWH. The success rate of replantation, when analysed by digits, was reported as 91.2% success in the LMWH group and 82.1% in the control group (RR 1.11, 95% CI 0.93 to 1.33; 73 digits, 1 study; very low‐certainty evidence). Compromised microcirculation requiring surgical re‐exploration, analysed by digits, was 11.8% in the LMWH group and 17.9% in the control group (RR 0.86, 95% CI 0.21 to 3.58; 73 digits, 1 study; very low‐certainty evidence). Compromised microcirculation requiring incision occurred in five out of 34 digits (14.7%) in the LMWH group and eight out of 39 digits (20.5%) in the control group (RR 0.72, 95% CI 0.26 to 1.98; 73 digits; very low‐certainty evidence). Microvascular insufficiency due to arterial occlusion, analysed by digits, was 11.8% in the LMWH group and 17.9% in the control group (RR 0.66, 95% CI 0.21 to 2.05; 73 digits, 1 study; very low‐certainty evidence), and venous occlusion was 14.7% in the LMWH group and 20.5% in the control (RR 0.72, 95% CI 0.26 to 1.98; 73 digits, 1 study; very low‐certainty evidence). The study did not report complications or adverse effects. </p> </section> <section id="CD009894-sec-0007"> <h3 class="title" id="CD009894-sec-0007">Authors' conclusions</h3> <p>There is currently low to very low‐certainty evidence, based on four RCTs, suggesting no evidence of a benefit from LMWH when compared to UFH on the success rates of replantation or affect microvascular insufficiency due to vessel occlusion (analysed by digit or participant). LMWH had similar success rates of replantation; and the incidence rate of venous and arterial microvascular insufficiency showed no evidence of a difference between groups when LMWH was compared to no LMWH (analysed by digit). Similar rates of complications and adverse effects were seen between UFH and LMWH. There was insufficient evidence to draw conclusions on any effect on coagulation when comparing LMWH to UFH or no LMWH. The certainty of the evidence was downgraded due to performance and reporting bias, as well as imprecision in the results. Further adequately powered studies are warranted to provide high‐certainty evidence. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009894-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009894-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009894-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009894-abs-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009894-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009894-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009894-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009894-abs-0002" lang="en"> <h3>Low molecular weight heparin for preventing blockage of blood vessels in replanted fingers or toes after amputation injuries </h3> <p><b>Background</b> </p> <p>Microvascular surgery refers to any surgery involving small‐sized blood vessels that is performed under the operating microscope, allowing, for example, for the repair of arteries and veins of amputated parts to the body. These vessels are typically 1 mm to 2 mm in diameter. Replantation is the reattachment of a completely detached body part, with fingers and thumbs being the most commonly replanted body parts. This is often referred to as digital replantation. In principle, digital replantation involves not only restoring the blood flow through the arteries and veins but also restoring the bony skeleton of the toes, fingers or thumbs, along with repairing the tendons and nerves, if necessary. Occlusion (blockage) of one or more of the repaired vessels due to the formation of a clot within the blood vessel can result in failure of the replantation. Anticoagulant medications are used to reduce clotting, and they could potentially prevent such a complication. Anticoagulants such as unfractionated heparin (UFH) have therefore been used to prevent clot formation after digital replantation. It is unclear if low molecular weight heparin (LMWH) has similar benefit. </p> <p><b>Key results</b> </p> <p>A randomised controlled trial (RCT) is a clinical study in which people have an equal chance of receiving the treatment or a comparator. This systematic review identified four RCTs comparing LMWH with either UFH or no LMWH. The trials included a total of 258 people with at least 273 replanted fingers or toes (digits). The evidence is up‐to‐date to 17 March 2020. The trials differed in which results they reported and how they reported them, so we could not combine all the information. </p> <p>Three trials showed no evidence of a benefit of LMWH when compared with UFH in the success rate of replantation, microvascular insufficiency due to vessel occlusion (poor blood flow due to blockages in the small‐sized blood vessels), and side effects such as bleeding. There was no evidence of clear differences between the use of LMWH or no LWMH in the success rate of replantation in one study. Similarly, no evidence of clear differences in the incidence of reduced blood flow (compromised microcirculation) requiring further microvascular surgery (re‐exploration or incision), or causes of microvascular insufficiency due to vessel blockage, were detected in the study which analysed by digits or people. </p> <p>The limited evidence, which we judged to be of low to very low certainty, suggests there is no clear benefit of LMWH in increasing the success rate of replantation or preventing microvascular occlusion in digital replantation when compared to UFH or no LMWH. </p> <p><b>Certainty of the evidence</b> </p> <p>The overall certainty of evidence is very low due to limitations in study design and reporting. For example, the studies did not take measures to hide from a person which treatment they had, and they reported results that were not stated in the original plan. The sample size of included studies was not large enough to provide precise effect estimates. There is a need for large studies that are designed to reduce these study limitations. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009894-sec-0104" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009894-sec-0104"></div> <h3 class="title" id="CD009894-sec-0105">Implications for practice</h3> <section id="CD009894-sec-0105"> <p>There is currently low to very low‐certainty evidence, based on four RCTS, suggesting no evidence of a benefit from low molecular weight heparin (LMWH) on the success rates of replantation or affect microvascular insufficiency due to vessel occlusion when compared to unfractionated heparin (UFH) (analysed by digit or participant). LMWH had similar success rates of replantation; and the incidence rate of venous and arterial microvascular insufficiency showed no evidence of a difference between groups when LMWH was compared to no LMWH (analysed by digit). Similar rates of complications and adverse effects were seen between UFH and LMWH. There was insufficient evidence to draw conclusions on any effect on coagulation when comparing LMWH to UFH or no LMWH. The certainty of evidence was downgraded due to the presence of performance and reporting bias, as well as imprecision in the results. </p> </section> <h3 class="title" id="CD009894-sec-0106">Implications for research</h3> <section id="CD009894-sec-0106"> <p>Additional randomised controlled trials (RCTs) with adequate blinding, prespecified outcomes, and with adequate sample size should be conducted to provide evidence regarding the effects of LMWH in this population. Replantation success may also be related to anastomosis technique, quality of the chosen vessels to anastomose, and quality of the tissue around anastomosis. None of these factors were reported by the included trials, however, randomisation may mitigate these confounders. Detailed information of interventions (including dosage, treatment duration, costs, and compromised microcirculation requiring further invasive interventions) and definition of successful replantation should be reported to optimise the treatment regimen and to allow for subgroup analyses. Further studies that include all anticoagulants and their application in replantation or microsurgery are warranted. </p> <p>Given that digital replantations are uncommon and will likely decline further with improved workplace regulations, conducting RCTs in this area may not be feasible. In absence of RCTs, cohort studies from large databases might provide an alternative to assess the causality between the use of anticoagulant agents and success rate of replantation. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009894-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009894-sec-0029"></div> <div class="table" id="CD009894-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Low molecular weight heparin versus unfractionated heparin for prevention of microvascular occlusion in digital replantation</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>LMWH versus UFH for prevention of microvascular occlusion in digital replantation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients undergoing digital replantation after traumatic amputation<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> LMWH<br/> <b>Comparison:</b> UFH </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with UFH</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with LMWH</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Success rate of replantation</b><sup>1</sup> </p> <p>(analysed by participant, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.98<br/> (0.87 to 1.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>130<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>910 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>892 per 1000<br/> (792 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Success rate of replantation</b><sup>1</sup> </p> <p>(analysed by digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/> (0.90 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>950 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>922 per 1000<br/> (855 to 989) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of compromised microcirculation requiring invasive intervention (re‐exploration</b>) </p> <p>(analysed by participant/digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>, <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> or <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Incidence of compromised microcirculation requiring invasive intervention (incision)</b> </p> <p>(analysed by participant/digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>, <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> or <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Microvascular insufficiency due to vessel occlusion ‐ arterial occlusion</b> </p> <p>(analysed by participant/digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.08<br/> (0.16 to 7.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>54<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>77 per 1000<br/> (11 to 507) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Microvascular insufficiency due to vessel occlusion ‐ venous occlusion</b> </p> <p>(analysed by participant, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.81<br/> (0.20 to 3.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>54<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>116 per 1000<br/> (26 to 522) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Complication and adverse reactions ‐ wound bleeding</b> </p> <p>(analysed by participant, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.53<br/> (0.23 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>130<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000<br/> (48 to 257) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>LMWH</b> : low molecular weight heparin; <b>RR:</b> risk ratio; <b>UFH</b>: unfractionated heparin </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Success rate of replantation was study‐based on physician judgement, with no exact definition.<br/> <sup>2</sup> Follow‐up is defined as unclear as there were no available data about duration to follow‐up in <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> and <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>. <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> mentioned follow up at 14 days post surgery.<br/> <sup>3</sup> We downgraded the level of certainty of evidence from high to very low based on the following reasons: there was a high risk of performance bias and reporting bias; and only two trials with small numbers of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>).<br/> <sup>4</sup> We downgraded the level of certainty of evidence from high to low based on the following reasons: there was a high risk of performance bias; and only two trials with small numbers of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>).<br/> <sup>5</sup> We downgraded the level of certainty of evidence from high to very low based on the following reasons: there was a high risk of performance bias and reporting bias; and only one trial with a small number of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>).<br/> <sup>6</sup> We downgraded the level of certainty of evidence from high to low based on the following reasons: there was a high risk of performance bias; and only two trials with small numbers of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009894-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Low molecular weight heparin (LMWH) versus no LMWH for prevention of microvascular occlusion in digital replantation</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>LMWH versus no LMWH for prevention of microvascular occlusion in digital replantation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients undergoing digital replantation after traumatic amputation<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> LMWH<br/> <b>Comparison:</b> control (no LMWH) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control (no LMWH)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with LMWH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Success rate of replantation</b><sup>1</sup> </p> <p>(analysed by participant)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Success rate of replantation</b><sup>1</sup> </p> <p>(analysed by digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.11<br/> (0.93 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>821 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>911 per 1000<br/> (763 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Incidence of compromised microcirculation requiring invasive intervention (re‐exploration)</b> </p> <p>(analysed by digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/> (0.21 to 3.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>88 per 1000<br/> (22 to 367) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Incidence of compromised microcirculation requiring invasive intervention (incision)</b> </p> <p>(analysed by digit, follow‐up unclear<sup>3</sup>) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.72<br/> (0.26 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>73<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>205 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>148 per 1000<br/> (53 to 406) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Microvascular insufficiency due to vessel occlusion ‐ arterial occlusion</b> </p> <p>(analysed by digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/> (0.21 to 2.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>118 per 1000<br/> (38 to 368) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Microvascular insufficiency due to vessel occlusion ‐ venous occlusion</b> </p> <p>(analysed by digit, follow‐up 7 day post surgery<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.72<br/> (0.26 to 1.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>205 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>148 per 1000<br/> (53 to 406) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Complication and adverse reactions ‐ wound bleeding</b> </p> <p>(analysed by participant, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>LMWH:</b> low molecular weight heparin; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The success rate of replantation in <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> was study‐based on physician judgement, with no exact definition.<br/> <sup>2</sup> Follow‐up is judged as unclear as there were no available data on duration to follow‐up in <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>.<br/> <sup>3</sup> We downgraded the level of certainty of evidence from high to very low based on the following reasons: there was a high risk of performance and reporting bias; and only one trial with a small number of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009894-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009894-sec-0030"></div> <section id="CD009894-sec-0031"> <h3 class="title" id="CD009894-sec-0031">Description of the condition</h3> <p>Digital replantation is an established microsurgical procedure in traumatic hand surgery, with reported success rates as high as 90% (<a href="./references#CD009894-bbs2-0053" title="LevinLS , CooperEO . Clinical use of anticoagulants following replantation surgery. Journal of Hand Surgery2008;33(8):1437‐9. ">Levin 2008</a>). The success is highly dependent on maintaining the patency of the repaired blood vessels after satisfactory microvascular anastomosis. The quality of the chosen vessels to anastomose is one of the key factors in determining whether postoperative treatments are needed or not. Microvascular occlusion can result from either venous or arterial thrombosis or, less frequently, a combination of both. Arterial thrombi, which usually present in areas of high or disturbed blood flow or at sites of endothelial damage, are formed primarily of platelet aggregates bound together by thin fibrin strands; thus both platelet activation and the coagulation cascade are important in its thrombogenesis. Venous thrombi, on the other hand, present in areas of stasis and are formed primarily by red blood cells and fibrin, and less so by platelets; thus the coagulation cascade plays a much more prominent role than platelet activation in their aetiology (<a href="./references#CD009894-bbs2-0027" title="ConradMH , AdamsWPJr . Pharmacologic optimization of microsurgery in the new millennium. Plastic and Reconstructive Surgery2001;108(7):2088‐96. ">Conrad 2001</a>). Studies on replantation of the digits and free‐tissue transfer have indicated that the highest risk of critical thrombosis following microvascular anastomosis is in the first three days following surgery. The risk is then reduced but still exists up to two weeks after surgery (<a href="./references#CD009894-bbs2-0021" title="BetancourtFM , MahET , McCabeSJ . Timing of critical thrombosis after replantation surgery of the digits. Journal of Reconstructive Microsurgery1998;14(5):313‐6. ">Betancourt 1998</a>; <a href="./references#CD009894-bbs2-0050" title="KrollSS , SchustermanMA , ReeceGP , MillerMJ , EvansGR , RobbGL , et al. Timing of pedicle thrombosis and flap loss after free‐tissue transfer. Plastic and Reconstructive Surgery1996;98(7):1230‐3. ">Kroll 1996</a>). Venous thrombosis is reported to occur more often than arterial thrombosis. Nevertheless, 90% of arterial thrombi occur within 24 hours post‐replantation while the majority of venous thromboses tend to occur after the first 24 hours (<a href="./references#CD009894-bbs2-0017" title="AskariM , FisherC , WenigerFG , BidicS , LeeWP . Anticoagulation therapy in microsurgery: a review. Journal of Hand Surgery2006;31(5):836‐46. ">Askari 2006</a>; <a href="./references#CD009894-bbs2-0050" title="KrollSS , SchustermanMA , ReeceGP , MillerMJ , EvansGR , RobbGL , et al. Timing of pedicle thrombosis and flap loss after free‐tissue transfer. Plastic and Reconstructive Surgery1996;98(7):1230‐3. ">Kroll 1996</a>; <a href="./references#CD009894-bbs2-0053" title="LevinLS , CooperEO . Clinical use of anticoagulants following replantation surgery. Journal of Hand Surgery2008;33(8):1437‐9. ">Levin 2008</a>). Some hospitals or surgical units use artery‐only replantation techniques with the use of anticoagulation to maintain venous outflow until it is re‐established naturally. This is particularly the case for more distal amputations (e.g. those distal to the distal interphalangeal joint) or where the damage is too severe for venous anastomosis to be feasible (<a href="./references#CD009894-bbs2-0051" title="LeeJY , KimHS , HeoST , KwonH , JungSN . Controlled continuous systemic heparinization increases success rate of artery‐only anastomosis replantation in single distal digit amputation: a retrospective cohort study. Medicine2016;95(26):e3979. [DOI: 10.1097/MD.0000000000003979] ">Lee 2016</a>). </p> <p>The use of prophylactic antithrombotic agents is the most commonly reported adjunctive strategy for avoiding vascular thrombosis after vascular repair. A variety of anticoagulation protocols are used by microsurgeons. Current protocols include the use of antithrombotic agents such as aspirin, intravenous heparin, low molecular weight heparins (LMWHs) or intravenous dextran, as well as local heparin delivery through direct injection or continuous drip on an open incision (<a href="./references#CD009894-bbs2-0017" title="AskariM , FisherC , WenigerFG , BidicS , LeeWP . Anticoagulation therapy in microsurgery: a review. Journal of Hand Surgery2006;31(5):836‐46. ">Askari 2006</a>; <a href="./references#CD009894-bbs2-0020" title='BarnettGR , TaylorGI , MutimerKL . The "chemical leech": intra‐replant subcutaneous heparin as an alternative to venous anastomosis. Report of three cases. British Journal of Plastic Surgery1989;42(5):556‐8. '>Barnett 1989</a>; <a href="./references#CD009894-bbs2-0022" title="BuckleyT , HammertWC . Anticoagulation following digital replantation. Journal of Hand Surgery2011;36(8):1374‐6. ">Buckley 2011</a>; <a href="./references#CD009894-bbs2-0044" title="IglesiasM , ButrónP . Local subcutaneous heparin as treatment for venous insufficiency in replanted digits. Plastic and Reconstructive Surgery1999;103(6):1719‐24. ">Iglesias 1999</a>). However, the optimum dosage and duration of administration of these agents remains complicated by the wide variability of antithrombotic prophylaxis protocols practiced among different surgical units. </p> </section> <section id="CD009894-sec-0032"> <h3 class="title" id="CD009894-sec-0032">Description of the intervention</h3> <p>Unfractionated heparin (UFH) is a glycosaminoglycan polymer of varying lengths and is the most widely used anticoagulant agent for preventing both arterial and venous thrombosis (<a href="./references#CD009894-bbs2-0070" title="StockmansF , StassenJM , VermylenJ , HoylaertsMF , NystromA . A technique to investigate microvascular mural thrombus formation in arteries and veins: II. Effects of aspirin, heparin, r‐hirudin and G‐4120. Annals of Plastic Surgery1997;38(1):63‐8. ">Stockmans 1997</a>). Heparin maintains the patency of microvascular anastomoses because it inhibits the synthesis of thrombin. This in turn leads to an improved survival rate of digital replantation. However, heparin prophylaxis is limited by an increased risk of haemorrhage from the surgical site, formation of haematoma, heparin‐induced thrombocytopenia (<a href="./references#CD009894-bbs2-0024" title="ChongBH , FawazI , ChestermanCN , BerndtMC . Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with platelets. British Journal of Haematology1989;73(2):235‐40. ">Chong 1989</a>), and requirement for transfusion (<a href="./references#CD009894-bbs2-0045" title="IsaacsIJ . The vascular complications of digital replantation. Australian and New Zealand Journal of Surgery1977;47(3):292‐9. ">Isaacs 1977</a>). Low‐dose regimens are attractive from the standpoint of bleeding complications (<a href="./references#CD009894-bbs2-0049" title="KrollSS , MillerMJ , ReeceGP , BaldwinBJ , RobbGL , BengtsonBP , et al. Anticoagulants and hematomas in free flap surgery. Plastic and Reconstructive Surgery1995;96(3):643‐7. ">Kroll 1995</a>), but they have been reported as less effective compared to full heparinising doses (<a href="./references#CD009894-bbs2-0041" title="HendelPM . Pharmacologic agents in microvascular surgery. In: BunckeHJ , FurnasDW editor(s). Symposium on clinical frontiers in reconstructive microsurgery. St. Louis: CV Mosby, 1984:427. ">Hendel 1984</a>). On the contrary, LMWH is a group of antithrombotic agents with different individual properties. LMWH is derived from UFH and has been reported to be as efficacious as heparin in preventing thrombosis. It has enhanced bioavailability as it binds loosely to protein and interacts less with platelets. In comparison to UFH it has fewer adverse effects. The LMWHs have a long half‐life with a very predictable dose‐response relationship, which minimises the need for monitoring. Furthermore, LMWH is associated with reduced risk of bleeding and a lower risk of heparin‐induced osteoporosis. In addition, it has been shown that short‐term use of LMWH is less frequently associated with undesirable heparin‐induced thrombocytopenia (HIT) compared with UFH (<a href="./references#CD009894-bbs2-0031" title="FranklinRD , KuttehWH . Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstetrics and Gynecology2003;101(3):455‐62. ">Franklin 2003</a>; <a href="./references#CD009894-bbs2-0074" title="WarkentinTE , LevineMN , HirshJ , HorsewoodP , RobertsRS , GentM , et al. Heparin‐induced thrombocytopenia in patients treated with low‐molecular‐weight heparin or unfractionated heparin. The New England Journal of Medicine1995;332(20):1330‐5. ">Warkentin 1995</a>). </p> </section> <section id="CD009894-sec-0033"> <h3 class="title" id="CD009894-sec-0033">How the intervention might work</h3> <p>When the vessel wall is injured, collagen and tissue factor become exposed to the flowing blood, thereby initiating a proteolytic cascade that leads to the formation of a thrombus (<a href="./references#CD009894-bbs2-0034" title="FurieB , FurieBC . Mechanisms of thrombus formation. The New England Journal of Medicine2008;359(8):938‐49. ">Furie 2008</a>). Exposed tissue factor triggers the formation of thrombin. Unlike the formation of thrombi in large‐sized vessels, thrombus formation in small vessels, such as the digital artery, may completely occlude the blood flow to the tissues supplied by the artery. Similarly, thrombus formation in the digital vein impedes proper venous outflow, which will eventually lead to arterial thrombosis. Both UFH and LMWH exert their anticoagulant activity by activating antithrombin (also known as antithrombin III), which in turn inhibits thrombin and activated factor Xa (factor Xa) to prevent both arterial and venous thrombosis (<a href="./references#CD009894-bbs2-0043" title="HirshJ , WarkentinTE , ShaughnessySG , AnandSS , HalperinJL , RaschkeR , et al. Heparin and low‐molecular‐weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest2001;119(1 Suppl):64S‐94S. ">Hirsh 2001</a>; <a href="./references#CD009894-bbs2-0076" title="WolfH . Low‐molecular‐weight heparin. Medical Clinics of North America1994;78(3):733‐43. ">Wolf 1994</a>). Although systemic anticoagulant therapy does not improve the patency rate when sharply divided vessels are repaired (<a href="./references#CD009894-bbs2-0030" title="ElcockHW , FredricksonJM . The effect of heparin on thrombosis at microvenous anastomotic sites. Archives of Otolaryngology1972;95(1):68‐71. ">Elcock 1972</a>; <a href="./references#CD009894-bbs2-0047" title="KetchumLD . Pharmacological alterations in the clotting mechanism: use in microvascular surgery. Journal of Hand Surgery1978;3(5):407‐15. ">Ketchum 1978</a>), a laboratory study showed a dramatic improvement in the patency rate following repair of traumatised vessels using systemic anticoagulant as an adjunct (<a href="./references#CD009894-bbs2-0028" title="CooleyBC , HansenFC . Microvascular repair following local crush and avulsion vascular injury. Microsurgery1985;6(1):46‐8. ">Cooley 1985</a>). In a retrospective study, it was found that 20% of replantation failures occurred within four hours of discontinuing systemic heparin (<a href="./references#CD009894-bbs2-0041" title="HendelPM . Pharmacologic agents in microvascular surgery. In: BunckeHJ , FurnasDW editor(s). Symposium on clinical frontiers in reconstructive microsurgery. St. Louis: CV Mosby, 1984:427. ">Hendel 1984</a>). Although re‐endothelialisation begins immediately after vascular repair, some form of anticoagulant therapy should be continued for at least three to five days, that is until the endothelium regenerates and covers the anastomotic site (<a href="./references#CD009894-bbs2-0025" title="ChowSP . The histopathology of microvascular anastomosis: a study of the incidence of various tissue changes. Microsurgery1983;4(1):5‐9. ">Chow 1983</a>; <a href="./references#CD009894-bbs2-0057" title="MorecraftR , BlairWF , ChangL . Histopathology of micro‐venous repair. Microsurgery1985;6(4):219‐28. ">Morecraft 1985</a>; <a href="./references#CD009894-bbs2-0069" title="ServantJM , IkutaY , HaradaY . A scanning electron microscope study of microvascular anastomoses. Plastic and Reconstructive Surgery1976;57(3):329‐34. ">Servant 1976</a>). The LMWHs are produced by either chemical or enzymatic depolymerization of UFH, resulting in the same inhibitory effect on active factor X but with relatively less anti‐IIa (thrombin) activity and thus less effect on the clotting time than UFH (<a href="./references#CD009894-bbs2-0075" title="WeitzJI . Low‐molecular‐weight heparins. The New England Journal of Medicine1997;337(10):688‐98. ">Weitz 1997</a>). </p> </section> <section id="CD009894-sec-0034"> <h3 class="title" id="CD009894-sec-0034">Why it is important to do this review</h3> <p>There are conflicting reports on both the efficacy and adverse effects of anticoagulants in preventing microvascular thrombosis (<a href="./references#CD009894-bbs2-0058" title="NiibayashiH , TamuraK , FujiwaraM , IkedaN . Survival factors in digital replantation: significance of postoperative anaemia. Journal of Hand Surgery2000;25(5):512‐5. ">Niibayashi 2000</a>; <a href="./references#CD009894-bbs2-0072" title="VeravuthipakornL , VeravuthipakornA . Microsurgical free flap and replantation without antithrombotic agents. Journal of the Medical Association of Thailand2004;87(6):665‐9. ">Veravuthipakorn 2004</a>; <a href="./references#CD009894-bbs2-0073" title="VretosKA , TsavissisAG . Antithrombotic and antiinflammatory drugs for protection of microvascular anastomosis. Acta Orthopaedica Scandinavica. Supplementum1995;264:48‐9. ">Vretos 1995</a>), and there is little objective evidence to demonstrate their beneficial effects in digital replantation. In addition, many surgeons favour their own particular protocols, that are derived by trial and error, for perioperative anticoagulation. No consensus or standard exists on the use of LMWH as an antithrombotic agent. As such, there is a strong need to review the effects of LMWH in digital replantation. The previous version of this review included two trials (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>); thus the data available were limited (<a href="./references#CD009894-bbs2-0082" title="ChenYC , ChiCC , ChanFC , WenYW . Low molecular weight heparin for prevention of microvascular occlusion in digital replantation. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD009894.pub2] ">Chen 2013</a>). This update includes the most recent available evidence. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009894-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009894-sec-0035"></div> <p>To assess if treatment with subcutaneous low molecular weight heparin (LMWH) improves the salvage rate of the digits in patients with digital replantation after traumatic amputation. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009894-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009894-sec-0036"></div> <section id="CD009894-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009894-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs), with or without blinding of participants or outcome assessors. We also included studies which used alternative methods of randomisation such as alternate days of the week, odd or even dates of birth, or hospital number (quasi‐randomised studies). We excluded studies that used historical controls. </p> </section> <section id="CD009894-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included all patients who suffered from traumatic digital amputation and received salvage microvascular replantation. </p> </section> <section id="CD009894-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included studies in which patients with traumatic digital amputation were randomised to receive subcutaneous LMWH versus any other treatment (such as another anticoagulant, placebo or no intervention) after digital replantation in order to prevent microvascular occlusion. We excluded trials that used LMWH for therapeutic purposes in established microvascular occlusion of replanted digits. </p> </section> <section id="CD009894-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD009894-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009894-list-0001"> <li> <p>Success rate of replantation, defined as the survival rate of replanted digits judged by the physician clinically, by means of excluding necrotic digits </p> </li> <li> <p>Incidence of compromised microcirculation requiring invasive interventions such as re‐exploration, re‐anastomosis, removal of nail, and incision </p> </li> </ul> </p> </section> <section id="CD009894-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009894-list-0002"> <li> <p>Microvascular insufficiency due to vessel occlusion (arterial occlusion, venous occlusion, or both) </p> </li> <li> <p>Microvascular insufficiency due to other/systemic causes (shock, infection, peripheral vascular pathology, hypercoagulopathy, etc.) </p> </li> <li> <p>Complications and adverse effects related to the interventions (haemorrhage, thrombocytopenia, etc.) </p> </li> <li> <p>Coagulation abnormalities</p> </li> </ul> </p> </section> </section> </section> <section id="CD009894-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <p>The searches were not limited by language or publication status.</p> <section id="CD009894-sec-0045"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist conducted systematic searches of the following databases for RCTs and controlled clinical trials. There were no restrictions on language, publication year or publication status. </p> <p> <ul id="CD009894-list-0003"> <li> <p>Cochrane Vascular Specialised Register, via the Cochrane Register of Studies (CRS‐Web, searched to 17 March 2020) </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) Cochrane Register of Studies Online (2020, Issue 2) </p> </li> <li> <p>MEDLINE (Ovid MEDLINE® Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE® Daily and Ovid MEDLINE®) (searched from 1 January 2017 to 17 March 2020) </p> </li> <li> <p>Embase Ovid (searched from 1 January 2017 to 17 March 2020)</p> </li> <li> <p>CINAHL Ebsco (searched from 1 January 2017 to 17 March 2020)</p> </li> <li> <p>AMED Ovid (searched from 1 January 2017 to 17 March 2020)</p> </li> </ul> </p> <p>The Information Specialist modelled search strategies for other databases on the search strategy designed for CENTRAL. Where appropriate, they were combined with adaptations of the highly sensitive search strategy designed by Cochrane for identifying RCTs and controlled clinical trials (as described in Chapter 6 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009894-bbs2-0052" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from training.cochrane.org/handbook. ">Lefebvre 2011</a>). Search strategies for major databases are provided in <a href="./appendices#CD009894-sec-0110">Appendix 1</a>. </p> <p>The Information Specialist searched the following trials registries on 17 March 2020.</p> <p> <ul id="CD009894-list-0004"> <li> <p>The World Health Organization International Clinical Trials Registry Platform (<a href="http://who.int/trialsearch" target="_blank">who.int/trialsearch</a>) </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>) </p> </li> </ul> </p> <p>The review authors also searched PubMed, using the search strategy which is detailed in <a href="./appendices#CD009894-sec-0111">Appendix 2</a>, as well as China National Knowledge Infrastructure (<a href="http://new.big5.oversea.cnki.net/index/" target="_blank">CNKI</a>) and Chinese Electronic Periodical Services (<a href="http://www.airitilibrary.com/" target="_blank">CEPS</a>), using Chinese synonyms modified from the PubMed search strategy (<a href="./appendices#CD009894-sec-0112">Appendix 3</a>; <a href="./appendices#CD009894-sec-0113">Appendix 4</a>). The search of PubMed, CNKI and CEPS were updated on 17 March 2020. </p> </section> <section id="CD009894-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We examined the reference lists of relevant review articles and all included trials to identify further studies. </p> </section> </section> <section id="CD009894-sec-0047"> <h3 class="title" id="CD009894-sec-0047">Data collection and analysis</h3> <section id="CD009894-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors (PL, CC) independently assessed all titles and abstracts of potentially eligible trials identified by the searches for inclusion in this review. We obtained the potentially relevant papers and assessed their full texts for inclusion eligibility. We resolved disagreements by discussion. </p> </section> <section id="CD009894-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (PL, CC) independently extracted data and checked them for accuracy. If relevant data could not be extracted, we tried to contact the primary authors of any articles and requested and included the additional unpublished data, when available. We resolved any discrepancies by discussion and consensus. </p> <p>We used a standard data extraction form to capture the following information.</p> <p> <ul id="CD009894-list-0005"> <li> <p>Characteristics of the study, including design, method of randomisation, allocation concealment, withdrawals or dropouts, and funding source </p> </li> <li> <p>Study participants, including mechanism of amputation and level of amputation</p> </li> <li> <p>Intervention (dosage and route of LMWH administration)</p> </li> <li> <p>Comparison intervention (placebo or other anticoagulant medication)</p> </li> <li> <p>Outcome measures, including replantation success rate (survival rate of digital replantation), incidence of microvascular insufficiency demanding invasive interventions, cause of microvascular occlusion, and complications </p> </li> </ul> </p> </section> <section id="CD009894-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (PL, CC) separately assessed the risk of bias of included studies using the following key domains: sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting, and other sources of bias. For each of these domains we assigned a judgement of low, high, or unclear risk of bias, using Cochrane's 'Risk of bias' tool (<a href="./references#CD009894-bbs2-0042" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook. ">Higgins 2011</a>). We resolved any disagreements by discussion. This information is presented in the <a href="./references#CD009894-sec-0124" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD009894-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes, we expressed data based on the number of events and the number of participants in the intervention and comparison groups. We used these to calculate the risk ratio (RR) and 95% confidence intervals (CIs). </p> <p>For continuous outcomes, we planned to express continuous data as mean differences (MDs) with 95% CIs. Where different outcome scales were reported, we planned to express continuous data as standardised mean differences (SMDs) with 95% CIs. </p> </section> <section id="CD009894-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>We expected to find only studies that randomised by individual patients. We planned to apply separate analyses if studies which randomised by digits were found, but this was not necessary. </p> </section> <section id="CD009894-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the original study authors to request missing information whenever possible. We used an intention‐to‐treat (ITT) approach. We reported on the levels of missing data and assessed this as a source of potential bias. </p> </section> <section id="CD009894-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed that the studies were clinically similar enough to allow pooling of data using meta‐analysis by considering their methodology. We examined between‐study heterogeneity by inspecting the forest plots and quantifying the impact of heterogeneity using the I<sup>2</sup> statistic. We interpreted an I<sup>2</sup> value greater than 50% as indicating possible heterogeneity. If statistical heterogeneity was indicated in relation to the study quality, participants, intervention regimens or outcome measurements we planned to apply a subgroup analysis to explore this. </p> </section> <section id="CD009894-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to use funnel plots to investigate the presence of publication bias in the included studies when at least 10 relevant trials for a primary outcome were available, or if any systematic differences existed between small and large studies. Insufficient studies were included in this update to allow for the construction of a funnel plot. </p> </section> <section id="CD009894-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We performed meta‐analyses using Review Manager 5 software (<a href="./references#CD009894-bbs2-0066" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). The decision to meta‐analyse data was based on whether the included trials were similar enough in terms of participants, settings, intervention, comparison and outcome measures to allow meaningful conclusions. For estimates of the RR we used the Mantel‐Haenszel method. For continuous variables, we planned to use the inverse variance method. We used a fixed‐effect model for the meta‐analyses. Had we identified cases where there was heterogeneity, we would have used a random‐effects model. </p> </section> <section id="CD009894-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform subgroup analyses according to the mechanism of digital amputation (for example guillotine, crush, avulsion, or degloving) and the level of digital amputation, when data were available. We also planned to perform a comparison of effects of different heparin doses if sufficient numbers of studies, or trials using different dosage regimens, were identified. However, we were unable to conduct these planned subgroup analyses due to lack of relevant data. </p> </section> <section id="CD009894-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We originally planned to conduct a sensitivity analysis by excluding studies judged to have a high risk of bias in any domain. However, we were unable to perform the planned sensitivity analysis because all included studies had a high risk of bias for at least one domain. </p> <section id="CD009894-sec-0059"> <h5 class="title">Summary of findings and assessment of the certainty of the evidence</h5> <p>As a post‐protocol addition, we have presented the main findings of this review update in 'Summary of findings' tables. In accordance with GRADE principles, as described by <a href="./references#CD009894-bbs2-0042" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook. ">Higgins 2011</a> and <a href="./references#CD009894-bbs2-0018" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490‐4. ">Atkins 2004</a>, we considered the certainty of evidence, magnitude of effect of interventions examined, and the sum of available data for the outcomes of this review. We presented the findings for the comparisons of LMWH versus unfractionated heparin (UFH) (<a href="./full#CD009894-tbl-0001">summary of findings Table for the main comparison</a>), and LMWH versus no LMWH (<a href="./full#CD009894-tbl-0002">summary of findings Table 2</a>). We used the GRADEpro GDT website (<a href="http://gradepro.org" target="_blank">gradepro.org</a>) to prepare the 'Summary of findings' tables. We used the GRADE system to describe the certainty of the evidence and the strength of recommendations (<a href="./references#CD009894-bbs2-0038" title="SchünemannH , BrozekJ , GuyattG , OxmanA (editors) . GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013. Available from guidelinedevelopment.org/handbook. ">GRADE 2013</a>; <a href="./references#CD009894-bbs2-0039" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383–94. ">Guyatt 2011</a>). We have expressed the certainty of evidence on a four‐point adjectival scale ranging from 'high' to 'very low'. We downgraded the certainty if there was unexplained, clinically important heterogeneity, the study methodology was at risk of bias, the evidence was indirect, there was important uncertainty around the estimate of effect, or if there was evidence for publication bias. Therefore, it was possible to grade the evidence at a very low certainty if several of these concerns were present. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009894-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009894-sec-0060"></div> <section id="CD009894-sec-0061"> <h3 class="title">Description of studies</h3> <section id="CD009894-sec-0062"> <h4 class="title">Results of the search</h4> <p>Our updated searches identified 628 additional records, of which 597 remained after duplicates were removed. We excluded 412 references based on titles and abstracts being irrelevant. Of the remaining 13 articles, we excluded 11 (see <a href="./references#CD009894-sec-0125" title="">Characteristics of excluded studies</a>). We included two new trials in this update (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). </p> <p>See <a href="#CD009894-fig-0001">Figure 1</a> for a PRISMA flow diagram illustrating the study selection process. </p> <div class="figure" id="CD009894-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009894-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD009894-sec-0063"> <h4 class="title">Included studies</h4> <p>Two additional studies met the inclusion criteria for this review (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). This brings the total number of studies included in the quantitative and qualitative analyses to four (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). The studies <br/>involved a total of 258 participants and at least 273 digits. </p> <p>Three RCTs compared LMWH with UFH (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>), and one RCT compared LMWH with no LMWH (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>). The types and dosages of LMWH used in three trials were not reported, and only the volumetric dosage was provided (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). For full details, see <a href="./references#CD009894-sec-0124" title="">Characteristics of included studies</a>. </p> <section id="CD009894-sec-0064"> <h5 class="title">Design</h5> <p>All four included studies were RCTs.</p> </section> <section id="CD009894-sec-0065"> <h5 class="title">Sample size</h5> <p><a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> enrolled 54 participants and did not reported the number of digits. <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> enrolled 60 participants with 69 either complete or incomplete amputated digits. <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> enrolled 76 participants with 131 amputated digits. <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> enrolled 68 participants with 73 amputated digits. </p> </section> <section id="CD009894-sec-0066"> <h5 class="title">Setting</h5> <p>All four included studies were set in hospitals in China.</p> </section> <section id="CD009894-sec-0067"> <h5 class="title">Study participants</h5> <p><a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> enrolled 54 participants and the mean age was 25.8 years in the treatment group and 26.6 years in the control group. In <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> 60 participants were enrolled, including 46 males and 14 females; the participants were aged between 17 and 43 years, with a mean age of 24.5. <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> enrolled 76 participants (40 males and 36 females) between 18 and 41 years of age; the mean age was 26 years. In <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> 68 participants were enrolled (59 males and nine females); the mean age was 36.2 years and the age range was 10 to 56 years. </p> <p>The participants in all four included trials received digital replantation for traumatic amputation. Only one trial reported the types of trauma, which consisted of injury by mechanical press (31 digits), chainsaw (30 digits), and cutting (12 digits) (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>). </p> </section> <section id="CD009894-sec-0068"> <h5 class="title">Interventions</h5> <p>Three RCTs compared LMWH with UFH (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>), and one RCT compared LMWH with no LMWH (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>). </p> <p>In <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>, 5000 international units (IU) subcutaneous (SC) LMWH (Livaracine) was administered 30 minutes before surgery, followed by 2500 to 5000 IU SC every 12 hours for 7 days in the LMWH group. The UFH group received 2500 IU intravenous (IV) UFH 30 minutes to 1 hour before surgery followed by 1250 IU every 12 hours for 7 to 10 days and low molecular weight dextran 500 mL twice a day. </p> <p>In <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>, the LMWH group received SC LMWH (exact type and dosage unknown) 0.4 mL every 12 hours for 7 to 10 days. The UFH group received 10,000 IU SC UFH every 12 hours for 7 to 10 days. Both groups also received 60 mg intramuscular (IM) papaverine every 6 hours for 7 to 10 days, low molecular weight dextran 500 mL intravenously every 12 hours for 7 to 10 days, dipyridamole 25 mg oral three times per day for 7 to 10 days, and aspirin 50 mg oral once daily for 7 to 10 days. </p> <p>In <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>, the LMWH group received LMWH (exact type and dosage unknown) 5000 IU SC every 12 hours for 7 days. The control group received heparin 12,500 IU in 1000 mL normal saline, run 24 drops per minute for 24 hours for 7 days. Both groups also received regular therapy with medicine to reduce or prevent infection, spasm, and platelet agglutination, and bed‐rest. </p> <p>In <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>, the LMWH group received LMWH (exact type and dosage unknown) 0.4 mL SC every 12 hours, while the control group did not receive LMWH. Both groups also received antibiotics, papaverine, aspirin, dipyridamole, and low molecular weight dextran. When venous circulation crisis (cold and pale skin due to poor blood circulation) occurred, the skin was incised and a dressing soaked in heparin diluted in normal saline was applied every 30 minutes. </p> </section> <section id="CD009894-sec-0069"> <h5 class="title">Outcomes</h5> <p>All four included trials reported the success rate of replantation. One study analysed the success rate of replantation by participants (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>), two studies analysed by digits (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>), and one study analysed by both participants and digits (<a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). </p> <p>Of the four included trials, one trial reported incidence of compromised microcirculation requiring re‐exploration and incision (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>); two trials mentioned microvascular insufficiency due to vessel occlusion (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>), and two trials reported complications and adverse events (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). Four trials mentioned coagulation abnormalities, including alterations in antithrombin activity, factor Xa activity, bleeding time, clotting time, activated partial thromboplastin time (aPTT), fibrinogen degradation product (FDP) concentration test, platelet count, and fibrinogen levels (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> measured aPTT at days 1 and 7 following replantation surgery, while <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> calculated the mean aPTT from day 1 to day 7 following replantation operation. </p> </section> </section> <section id="CD009894-sec-0070"> <h4 class="title">Excluded studies</h4> <p>We excluded 11 studies for this update, resulting in a total of 12 excluded studies (<a href="./references#CD009894-bbs2-0005" title="ChenSC , FengZT . Curative effect observation of Xueshuantong combined with low molecular weight heparin in prevention of thrombosis after replantation of amputated finger. Chinese Journal of Pharmacoepidemiology2015;3:148‐51. ">Chen 2015</a>; <a href="./references#CD009894-bbs2-0006" title="ChenBS , HouJ . Efficacy of low molecular weight heparin combined with felodipine in prevention of vascular crisis after finger replantation. Women's Health Research2016;21:153‐4. ">Chen 2016</a>; <a href="./references#CD009894-bbs2-0007" title="ChenX , ChenZ , ZhouJ , XuY . Unilateral digital arterial ligation combined with low molecular weight heparins in severed finger without venous anastomosis. Experimental and Therapeutic Medicine2018;16:342‐6. [DOI: 10.3892/etm.2018.6174] ">Chen 2018</a>; <a href="./references#CD009894-bbs2-0008" title="HanZM , DingYH . Influence of auxiliary application of Xuesaitong injection on blood coagulation indices and thromboembolic complications in patients after finger replantation. China Pharmacist2015;12:2087‐9. ">Han 2015</a>; <a href="./references#CD009894-bbs2-0009" title="LiY , WeiP , SunT , LiL , ZhouDY , ChenH , et al. Efficacy of low molecular weight heparin combined with felodipine on vascular crisis prevention after finger replantation. Chinese Journal of New Drugs and Clinical Remedies2012;31(10):607‐10. ">Li 2012b</a>; <a href="./references#CD009894-bbs2-0010" title="LiP , LiuY , SunF , WangT , SuJL , LiY . Clinical study of huoxue rongshuan decoction on preventing vascular crisis after skin flap transplantation for trauma. Chinese Archives of Traditional Chinese Medicine2016;33(2):2984‐7. ">Li 2016</a>; <a href="./references#CD009894-bbs2-0011" title="LiuY , LiY , YanW , WangT , SunF , SuQL , et al. Clinical study of huoxue rongshuan decoction on preventing vascular crisis after skin flap transplantation for trauma. Chinese Archives of Traditional Chinese Medicine2015;12:2984‐7. ">Liu 2015</a>; <a href="./references#CD009894-bbs2-0012" title="MaZX . Clinical application of low molecular weight heparin. Capital Medicine2017;6:48‐9. ">Ma 2017</a>; <a href="./references#CD009894-bbs2-0013" title="MengX , YueQ , YueWJ , LiW , MengQG . Clinical study on hemorheological effect of low molecular weight heparin calcium on small vascular injury. Progress in Modern Biomedicine2013;22:4284‐7. ">Meng 2013</a>; <a href="./references#CD009894-bbs2-0014" title="ShuT , LiSZ , MiaoZ . The efficacy and risk of intravenous heparin injection in digital replantation. Journal of Guangxi Medical University2011;28(5):731‐3. ">Shu 2011</a>; <a href="./references#CD009894-bbs2-0015" title="ZhaoCY , WeiLP , WangD , WanHX . Analysis on application effect of two different application methods of low molecular heparin in rescuing vein crisis after replantation of severed finger. Attend to Practice and Research2017;5:9‐11. ">Zhao 2017</a>; <a href="./references#CD009894-bbs2-0016" title="ZhouLZ , WuYQ , XiaoRY , HuangCH , LinWM , TengJM . Observation on the effect of low molecular weight heparin calcium in free flap transplantation. China Medicine and Pharmacy2017;13:56‐8. ">Zhou 2017</a>). The reasons for exclusion are listed in <a href="./references#CD009894-sec-0125" title="">Characteristics of excluded studies</a>. Nineteen previously excluded studies were reassessed as not relevant because they were not RCTs. </p> </section> </section> <section id="CD009894-sec-0071"> <h3 class="title">Risk of bias in included studies</h3> <p>Details of the methodological quality are reported in the individual study tables (<a href="./references#CD009894-sec-0124" title="">Characteristics of included studies</a>). We present the summarised risk of bias across all included studies in <a href="#CD009894-fig-0002">Figure 2</a> and the respective 'Risk of bias' item for each included study in <a href="#CD009894-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009894-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009894-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009894-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009894-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD009894-sec-0072"> <h4 class="title">Allocation</h4> <p>One trial used a randomisation table for sequence generation (<a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). The other included trials did not report the methods of random sequence generation. Thus we rated <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> as having low risk of bias for this domain, and the other trials as having an unclear risk of bias (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>). </p> <p>The method of allocation concealment was not reported by any of the included trials, and the risk of bias for allocation concealment was rated as unclear for all included studies (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). </p> </section> <section id="CD009894-sec-0073"> <h4 class="title">Blinding</h4> <p>One trial was at low risk of bias for blinding because both the participants and personnel were blinded, and both LMWH and UFH were administered SC every 12 hours for seven to 10 days (<a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>). We judged the remaining three trials to have a high risk of performance bias, because the experimental and control interventions were administered via different routes (SC and IV) (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). We rated <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>, <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>, and <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> as having unclear risk of detection bias because they did not report any methods for blinding outcome assessment. </p> </section> <section id="CD009894-sec-0074"> <h4 class="title">Incomplete outcome data</h4> <p>All included trials were classified as having unclear risk of bias for incomplete outcome data due to a lack of descriptions about dropouts or withdrawals. We contacted the authors of <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> to request data on the methods of randomisation and allocation, the statistical analysis of missing data, and the timing of outcome assessment. </p> </section> <section id="CD009894-sec-0075"> <h4 class="title">Selective reporting</h4> <p>Three included trials were classified as being at high risk of reporting bias, because the reported outcomes were not pre‐specified (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>). <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> and <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> reported both efficacy and safety outcomes, but <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> did not report on safety outcomes. We deemed <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> to be at low risk of reporting bias, because both the efficacy and safety outcomes were reported and were pre‐specified. </p> </section> <section id="CD009894-sec-0076"> <h4 class="title">Other potential sources of bias</h4> <p>We judged three of the trials to be at low risk of bias for other sources (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). These trials did not report which LMWH product was used and the exact dosage, however this would not affect the treatment analysis. </p> <p>The remaining trial also included amputations of the hand palm and forearm but the number was small (number (n) = 5) and presumed to be balanced between groups (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>). Low molecular weight dextran was used only in the UFH group; this might have influenced the results so we judged the study to be at unclear risk of other bias. </p> <p>The details are reported in the 'Risk of bias' tables, under <a href="./references#CD009894-sec-0124" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD009894-sec-0077"> <h3 class="title" id="CD009894-sec-0077">Effects of interventions</h3> <p>See: <a href="./full#CD009894-tbl-0001"><b>Summary of findings for the main comparison</b> Low molecular weight heparin versus unfractionated heparin for prevention of microvascular occlusion in digital replantation</a>; <a href="./full#CD009894-tbl-0002"><b>Summary of findings 2</b> Low molecular weight heparin (LMWH) versus no LMWH for prevention of microvascular occlusion in digital replantation</a> </p> <p>We were unable to pool the data from the four studies in one meta‐analysis as they compared LMWH to different control arms and analysed by different units. See <a href="./full#CD009894-tbl-0001">summary of findings Table for the main comparison</a> for the comparison LMWH versus UFH for prevention of microvascular occlusion in digital replantation; and <a href="./full#CD009894-tbl-0002">summary of findings Table 2</a> for the comparison LMWH versus no LMWH for prevention of microvascular occlusion in digital replantation. </p> <section id="CD009894-sec-0078"> <h4 class="title">Low molecular weight heparin versus unfractionated heparin</h4> <p>Three included trials compared LMWH with UFH and reported the efficacy and adverse effects (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). However, the trials used different units of analysis to report the success rate of replantation. We performed separate meta‐analyses accordingly. Only <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> reported the microvascular insufficiency due to vessel occlusion by participants; we also performed subgroup analyses for arterial and venous occlusion. Two trials reported complications and adverse reactions (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). There was a lack of relevant data for the other outcomes planned for this review. For this reason, we were not able to perform subgroup and sensitivity analyses. </p> <section id="CD009894-sec-0079"> <h5 class="title">Primary outcomes</h5> <section id="CD009894-sec-0080"> <h6 class="title">Success rate of replantation</h6> <p>The trials used different units of analysis to report data on this outcome. <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> reported the outcome by participants; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> reported it by digits; and <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> reported using both participants and digits. Pooling data from the studies showed no evidence if a difference in the success rate with LMWH and UFH, regardless of whether the outcome was assessed by number of participants (RR 0.98, 95% CI 0.87 to 1.10; 2 studies, 130 participants; very low‐certainty evidence), or by number of digits (RR 0.97, 95% CI 0.90 to 1.04; 2 studies, 200 digits; low‐certainty evidence). See <a href="./references#CD009894-fig-0004" title="">Analysis 1.1</a>. </p> </section> <section id="CD009894-sec-0081"> <h6 class="title">Incidence of compromised microcirculation requiring invasive interventions such as re‐exploration, re‐anastomosis, removal of nail, incision </h6> <p>This outcome was not mentioned in any of the included RCTs for this comparison.</p> </section> </section> <section id="CD009894-sec-0082"> <h5 class="title">Secondary outcomes</h5> <section id="CD009894-sec-0083"> <h6 class="title">Microvascular insufficiency due to vessel occlusion</h6> <p><a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> reported the incidence of postoperative arterial and venous occlusion separately (<a href="./references#CD009894-fig-0005" title="">Analysis 1.2</a>), but the authors did not clarify their definitions for these complications. Arterial occlusion occurred in 2 out of 26 participants (7.7%) in the LMWH group and 2 out of 28 participants (7.1%) in the UFH group (RR 1.08, 95% CI 0.16 to 7.10; 54 participants; very low‐certainty evidence). Compromised venous drainage occurred in 3 out of 26 participants (11.5%) in the LMWH group and 4 out of 28 participants (14.3%) in the UFH group (RR 0.81, 95% CI 0.20 to 3.27; 54 participants; very low‐certainty evidence). The incidence of arterial and venous occlusion showed no evidence of a difference between the LMWH and UFH groups. <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> and <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> did not report any data relevant to this outcome. </p> </section> <section id="CD009894-sec-0084"> <h6 class="title">Microvascular insufficiency due to other/systemic causes</h6> <p>This outcome was not mentioned in any of the included RCTs for this comparison.</p> </section> <section id="CD009894-sec-0085"> <h6 class="title">Complications and adverse effects related to the interventions</h6> <p><a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> did not report any data relevant to this outcome. <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> and <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> examined anticoagulation‐related complications and adverse effects, using participants as the unit of analysis (<a href="./references#CD009894-fig-0006" title="">Analysis 1.3</a>). Wound bleeding occurred in 7 participants (11.1%) in the LMWH group and 14 participants (20.9%) in the UFH group (RR 0.53, 95% CI 0.23 to 1.23; 130 participants, 2 studies; very low‐certainty evidence). Haematuria appeared in 2 participants (3.2%) of the LMWH group and 5 participants (7.5%) of the UFH group (RR 0.43, 95% CI 0.09 to 2.11; 130 participants, 2 studies; very low‐certainty evidence). Ecchymoses occurred in 3 participants (4.8%) in the LMWH group and 4 participants (6.0%) in the UFH group (RR 0.82, 95% CI 0.21 to 3.19; 130 participants, 2 studies; very low‐certainty evidence). Epistaxis occurred in 3 (4.5%) participants in the UFH group and 0 participants in the LMWH group (RR 0.27, 95% CI 0.03 to 2.32; 130 participants, 2 studies; very low‐certainty evidence). Gingival bleeding occurred in 5 (7.5%) of participants in the UFH group and 0 participants in the LMWH group (RR 0.18, 95% CI 0.02 to 1.43; 130 participants, 2 studies; very low‐certainty evidence). Faecal occult blood occurred in 3 participants (4.5%) in the UFH group and 0 participants in the LMWH group (RR 0.27, 95% CI 0.03 to 2.31; 130 participants, 2 studies; very low‐certainty evidence). </p> </section> <section id="CD009894-sec-0086"> <h6 class="title">Coagulation abnormalities</h6> <p>We could not perform a meta‐analysis for coagulation abnormality due to the variation of definitions and tests used. </p> <p><a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> monitored coagulability changes before anticoagulation and at 1 hour, 3 days, and 7 days after replantation. The study measured the following coagulation‐related outcomes (measured before treatment; after LMWH; and after UFH treatment, respectively): antithrombin activity (0.97; 1.22; 1.56), factor Xa activity (1.02; 0.37; 0.58), bleeding time (2 minutes 24 seconds; 3 minutes 18 seconds; 4 minutes 35 seconds), clotting time (8 minutes 55 seconds; 12 minutes 20 seconds; 25 minutes 32 seconds), activated partial thromboplastin time (aPTT) (41 seconds; 69 seconds; 85 seconds), and fibrinogen degradation product (FDP) concentration test (2.6 mg/L; 11.3 mg/L; 18.8 mg/L). No comparison was made between the LMWH and UFH groups, but the data suggest that coagulability reduced more in the UFH group than in the LMWH group (see <a href="#CD009894-tbl-0003">Table 1</a>). The study authors reported the mean value of the coagulation test by pooling the data at 1 hour, 3 days, and 7 days after surgery, but standard deviations were not available. Further statistical analysis was therefore not performed. </p> <div class="table" id="CD009894-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Coagulability measures in the Chen 2001 trial</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Coagulability measures</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Before treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>After LMWH treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>After UFH treatment</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Antithrombin activity</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.97</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.56</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Factor X<sub>a</sub> activity</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.58</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bleeding time</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 minutes 24 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 minutes 18 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 minutes 35 seconds</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clotting time</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 minutes 55 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 minutes 20 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 minutes 32 seconds</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>aPTT</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 seconds</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FDP concentration test</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.6 mg/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3 mg/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.8 mg/L</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>aPTT: activated partial thromboplastin time<br/> FDP: fibrinogen degradation product<br/> LMWH: low molecular weight heparin<br/> UFH: unfractionated heparin </p> </div> </div> <p><a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> measured the aPTT and reported no clear differences between the groups on the first postoperative day (LMWH: 28.4 ± 3.3 seconds; UFH: 29.5 ± 3.1 seconds; P &gt; 0.05). However, the difference increased during the second to seventh postoperative days (the aPTT on the seventh postoperative day for LMWH was 30.2 ± 2.1 seconds, and for UFH was 32.5 ± 2.2 seconds; P &lt; 0.05). It must be noted that aPTT changes were expected in the case of UFH, if given at large doses, as raised aPTT levels are a therapeutic target for UFH but not for LMWH. <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> did not directly compare the platelet counts of the LMWH and UFH groups. However, the platelet counts decreased postoperatively in the UFH group (preoperative: 278.4 ± 18.7 x 10<sup>9</sup>/L; postoperative: 194.3 ± 26.5 x 10<sup>9</sup>/L; P &lt; 0.05) but not in the LMWH group (preoperative: 260.8 ± 32.5 x 10<sup>9</sup>/L; postoperative: 252.4 ± 29.1 x 10<sup>9</sup>/L; P &gt; 0.05). </p> <p><a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> measured aPTT and platelet counts every day for one week after surgery. The mean aPTT differed between groups (LMWH: 65 ± 2.5 seconds; UFH: 86 ± 2.1 seconds). The UFH group (94 ± 24.1 x 10<sup>6</sup>/L) had lower mean platelet counts than the LMWH group (211 ± 20.4 x 10<sup>6</sup>/L). </p> <p>The level of aPTT, clotting time, and bleeding time were generally longer in the UFH group than the LMWH group, and the platelet count was generally lower in the UFH group than the LMWH group. </p> </section> </section> </section> <section id="CD009894-sec-0087"> <h4 class="title">Low molecular weight heparin versus no low molecular weight heparin</h4> <p>One trial compared the efficacy and adverse effects of LMWH with no LMWH (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>). The trial reported the success rate of replantation, microvascular insufficiency due to vessel occlusion, incidence of compromised microcirculation requiring re‐exploration and incision by digits. The control and LMWH groups also received antibiotics, papaverine, aspirin, dipyridamole, and low molecular weight dextran. </p> <section id="CD009894-sec-0088"> <h5 class="title">Primary outcomes</h5> <section id="CD009894-sec-0089"> <h6 class="title">Success rate of replantation</h6> <p>The trial analysed by digits. Success rates of replantation were 91.2% in the LMWH group and 82.1% in the control group (RR 1.11, 95% CI 0.93 to 1.33; 73 digits; very low‐certainty evidence). See <a href="./references#CD009894-fig-0007" title="">Analysis 2.1</a>. </p> </section> <section id="CD009894-sec-0090"> <h6 class="title">Incidence of compromised microcirculation requiring invasive interventions such as re‐exploration, re‐anastomosis, removal of nail, incision </h6> <p>The trial reported that compromised microcirculation requiring surgical re‐exploration occurred in 3 out of 34 digits (8.8%) in the LMWH group and 4 out of 39 digits (10.3%) in the control group (RR 0.86, 95% CI 0.21 to 3.58; 73 digits; very low‐certainty evidence). Compromised microcirculation requiring incision occurred in 5 out of 34 digits (14.7%) in the LMWH group and 8 out of 39 digits (20.5%) in the control group (RR 0.72, 95% CI 0.26 to 1.98; 73 digits; very low‐certainty evidence). See <a href="./references#CD009894-fig-0008" title="">Analysis 2.2</a>. </p> </section> </section> <section id="CD009894-sec-0091"> <h5 class="title">Secondary outcomes</h5> <section id="CD009894-sec-0092"> <h6 class="title">Microvascular insufficiency due to vessel occlusion</h6> <p>The trial reported that arterial occlusion occurred in 4 out of 34 participants (11.8%) in the LMWH group and 7 out of 39 participants (17.9%) in the control group (RR 0.66, 95% CI 0.21 to 2.05; 73 digits; very low‐certainty evidence). Compromised venous drainage occurred in 5 out of 34 digits (14.7%) in the LMWH group and 8 out of 39 digits (20.5%) in the control group (RR 0.72, 95% CI 0.26 to 1.98; 73 digits; very low‐certainty evidence). See <a href="./references#CD009894-fig-0009" title="">Analysis 2.3</a>. </p> </section> <section id="CD009894-sec-0093"> <h6 class="title">Microvascular insufficiency due to other/systemic causes</h6> <p><a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> did not report any data relevant to this outcome. </p> </section> <section id="CD009894-sec-0094"> <h6 class="title">Complications and adverse effects related to the interventions</h6> <p><a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> did not report any data relevant to this outcome. </p> </section> <section id="CD009894-sec-0095"> <h6 class="title">Coagulation abnormalities</h6> <p><a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> did not report any data relevant to this outcome. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009894-sec-0096" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009894-sec-0096"></div> <section id="CD009894-sec-0097"> <h3 class="title" id="CD009894-sec-0097">Summary of main results</h3> <p>The objective of this review was to compare subcutaneous low molecular weight heparin (LMWH) with other anticoagulants, placebo, or no treatment, to determine the efficacy and safety of LMWH in preventing microvascular occlusion following digital replantation after traumatic amputation. </p> <p>We found three randomised controlled trials (RCTs) that compared LMWH with unfractionated heparin (UFH) (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). Outcomes of meta‐analysis on efficacy did not favour LMWH over UFH, irrespective of the unit of analysis being the number of participants or number of digits. We were unable to perform a meta‐analysis for coagulation abnormality due to the variation in definitions used for this outcome. We found no clear differences between use of LMWH and UFH in terms of adverse effects, including haematuria, ecchymoses, epistaxis, gingival bleeding, and faecal occult blood (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>). Only <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> compared LMWH with no LMWH. Evidence was limited by the small number of participants; no clear benefit for the use of LMWH was observed. </p> </section> <section id="CD009894-sec-0098"> <h3 class="title" id="CD009894-sec-0098">Overall completeness and applicability of evidence</h3> <p>We conducted this review to assess whether LMWH treatment improves the salvage rate of digits in patients who had undergone digital replantation after traumatic amputation. In current clinical practice, there is no explicit guideline for the dose and treatment duration of anticoagulant agents after traumatic amputation. Surgeons use anticoagulant agents based on subjective judgement. </p> <p>The included trials were at high risk of bias for performance or selection bias (or both) and did not provide enough data to investigate all relevant types of injuries and surgical outcomes. Only <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> described the type of injuries, which included machine cutting injury, saw injury, machine run‐over injury, and mechanical press injury. Other studies did not mention type of injury, but <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> also included a small number of amputations of the hand palm and forearm. The type of LMWH used in this trial was not reported. The dosage of LMWH was not reported (only the volumetric dosage was provided). We therefore have limited confidence in generalising these results to other situations. </p> </section> <section id="CD009894-sec-0099"> <h3 class="title" id="CD009894-sec-0099">Quality of the evidence</h3> <p>We used the GRADE system to evaluate the certainty of the evidence for outcomes reported in this review. For each comparison and each outcome, we considered the risk of bias, imprecision, inconsistency, indirectness, and publication bias. See <a href="./full#CD009894-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD009894-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD009894-sec-0100"> <h4 class="title">Low molecular weight heparin versus unfractionated heparin</h4> <p>All three studies with this comparison reported on the outcomes success rate of replantation, complications, and adverse reactions (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). LMWH and UFH had similar efficacy on success rate of replantation. Analysis by unit of participants (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>) was downgraded to very low‐certainty evidence because of a high risk of performance bias, reporting bias, and small sample size (see <a href="#CD009894-sec-0071">Risk of bias in included studies</a>). In <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>, LMWH was administered subcutaneously but UFH was administered intravenously and outcomes of digital amputation (n = 46) were mixed with amputation of the hand palm (n = 3), forearm (n = 2), and toe (n = 3) and cannot be extracted. Low molecular weight dextran was used only in the UFH group, which might have biased the results. The definition of arterial and venous occlusion was not described. In <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>, LMWH and UFH were administrated by different routes and the type and dosage of LMWH used in this trial was not reported. The analysis by unit of digits was downgraded to low‐certainty evidence because of a high risk of performance bias and small sample size (<a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). LMWH and UFH were both administered subcutaneously in <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> , but not in <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>. </p> <p>The evidence for the outcome microvascular insufficiency due to vessel occlusion (analysis by unit of participants) was judged to be of very low certainty because of a high risk of performance bias, reporting bias, and imprecision (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>). </p> <p>The evidence for the outcome complications and adverse reactions (including wound bleeding) was judged to be of low certainty due to a high risk of performance bias in both trials reporting on this outcome (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). </p> </section> <section id="CD009894-sec-0101"> <h4 class="title">Low molecular weight heparin versus no low molecular weight heparin</h4> <p>There was one study within this comparison and it provided data on the outcomes success rate of replantation, incidence of compromised microcirculation requiring re‐exploration and incision, and microvascular insufficiency due to vessel occlusion (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>). </p> <p>There were similar success rates of replantation in the LMWH group and control group. The analysis was by unit of digits. We deemed the evidence for this outcome to be of very low certainty because of the high risk of performance bias and reporting bias, and the small sample size (<a href="#CD009894-sec-0071">Risk of bias in included studies</a>). </p> <p>The evidence for the outcome incidence of compromised microcirculation requiring re‐exploration and incision (analysis by unit of digits) was deemed to be of very low‐certainty because of the high risk of performance bias and reporting bias, and the small sample size. </p> <p>The outcomes of microvascular insufficiency due to vessel occlusion analysis (by unit of digits (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>)) were downgraded to very low‐certainty evidence, because of the high risk of performance bias and reporting bias, and the small sample size. </p> <p>The outcome of complications and adverse reactions (including wound bleeding) was not reported by <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>. </p> </section> </section> <section id="CD009894-sec-0102"> <h3 class="title" id="CD009894-sec-0102">Potential biases in the review process</h3> <p>We conducted the review according to the published protocol. We tried to avoid bias during the review process by searching a wide range of databases, including two databases in Mandarin (CNKI and CEPS). However, it is possible that some relevant trials published in different languages may not have been identified. Outcomes from replantation of three hand palms and two forearms were included in this review because <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> pooled these results with the results from digital replantation and they could not be extracted. However, since this trial was a RCT, we assumed these five amputations (5/54) were randomly distributed and were evenly represented in the LMWH and UFH groups. We were unable to establish contact with the trialists to confirm this. We redefined/rephrased two primary outcomes and two secondary outcomes since previous version of the review (<a href="./references#CD009894-bbs2-0082" title="ChenYC , ChiCC , ChanFC , WenYW . Low molecular weight heparin for prevention of microvascular occlusion in digital replantation. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD009894.pub2] ">Chen 2013</a>). This was due to clinical relevance or to clarify the outcomes further (see <a href="#CD009894-sec-0120">Differences between protocol and review</a>). Only RCTs were included in this review. It should be kept in mind that the systematic evaluation of adverse effects of LMWH or other anticoagulants may require other types of studies, such as cohort and case‐control studies (<a href="./references#CD009894-bbs2-0023" title="ChiCC , LeeCW , WojnarowskaF , KirtschigG . Safety of topical corticosteroids in pregnancy. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007346.pub2] ">Chi 2009</a>; <a href="./references#CD009894-bbs2-0026" title="Cochrane Adverse Effects Methods Group. methods.cochrane.org/adverseeffects/ (accessed 19 October 2012). ">Cochrane Adverse Effects Methods Group 2012</a>; <a href="./references#CD009894-bbs2-0055" title="LokeYK , PriceD , HerxheimerA , and the Cochrane Adverse Effects Methods Group. Systematic reviews of adverse effects: framework for a structured approach. BMC Medical Research Methodology2007;7:32. ">Loke 2007</a>). </p> </section> <section id="CD009894-sec-0103"> <h3 class="title" id="CD009894-sec-0103">Agreements and disagreements with other studies or reviews</h3> <p>Currently there is little evidence from RCTs to guide peri‐operative anticoagulation in digital replantation. The available evidence consists mainly of retrospective studies (<a href="./references#CD009894-bbs2-0022" title="BuckleyT , HammertWC . Anticoagulation following digital replantation. Journal of Hand Surgery2011;36(8):1374‐6. ">Buckley 2011</a>; <a href="./references#CD009894-bbs2-0032" title="FukuiA , MaedaM , SempukuT , TamaiS , MizumotoS , InadaY . Continuous local intra‐arterial infusion of anticoagulants for digit replantation and treatment of damaged arteries. Journal of Reconstructive Microsurgery1989;5(2):127‐36. ">Fukui 1989</a>; <a href="./references#CD009894-bbs2-0033" title="FukuiA , TamaiS . Present status of replantation in Japan. Microsurgery1994;15(12):842‐7. ">Fukui 1994</a>; <a href="./references#CD009894-bbs2-0040" title="HanSK , LeeBI , KimWK . Topical and systemic anticoagulation in the treatment of absent or compromised venous outflow in replanted fingertips. Journal of Hand Surgery2000;25(4):659‐67. ">Han 2000</a>; <a href="./references#CD009894-bbs2-0058" title="NiibayashiH , TamuraK , FujiwaraM , IkedaN . Survival factors in digital replantation: significance of postoperative anaemia. Journal of Hand Surgery2000;25(5):512‐5. ">Niibayashi 2000</a>; <a href="./references#CD009894-bbs2-0060" title="NoguchiM , MatsusakiH , YamamotoH . Intravenous bolus infusion of heparin for circulatory insufficiency after finger replantation. Journal of Reconstructive Microsurgery1999;15(4):245‐53. ">Noguchi 1999</a>; <a href="./references#CD009894-bbs2-0062" title="OufquirA , BakhachJ , PanconiB , GuimberteauJC , BaudetJ . Salvage of digit replantations by direct arterial antithrombotic infusion [Sauvetage des revascularisations digitales par administration intra‐artérielle de fibrinolytiques]. Annales De Chirurgie Plastique Esthetique2006;51(6):471‐81. ">Oufquir 2006</a>; <a href="./references#CD009894-bbs2-0064" title="PooleMD , BowenJE . Two unusual bleedings during anticoagulation following digital replantation. British Journal of Plastic Surgery1977;30(4):267‐8. ">Poole 1977</a>; <a href="./references#CD009894-bbs2-0065" title="RapoportS , GlickmanMG , SalomonJC , CuonoCB . Aggressive postoperative pharmacotherapy for vascular compromise of replanted digits. American Journal of Roentgenology, Radium Therapy and Nuclear Medicine1985;144(5):1065‐6. ">Rapoport 1985</a>; <a href="./references#CD009894-bbs2-0072" title="VeravuthipakornL , VeravuthipakornA . Microsurgical free flap and replantation without antithrombotic agents. Journal of the Medical Association of Thailand2004;87(6):665‐9. ">Veravuthipakorn 2004</a>; <a href="./references#CD009894-bbs2-0073" title="VretosKA , TsavissisAG . Antithrombotic and antiinflammatory drugs for protection of microvascular anastomosis. Acta Orthopaedica Scandinavica. Supplementum1995;264:48‐9. ">Vretos 1995</a>); comparative studies (<a href="./references#CD009894-bbs2-0019" title="AzolovVV , LadyginMS . Comparative characteristics of the effect of drugs on the microcirculation in reconstructive operations on the hand. Ortopediia Travmatologiia I Protezirovanie1983;6:47‐8. ">Azolov 1983</a>; <a href="./references#CD009894-bbs2-0035" title="FurnasHJ , LineaweaverW , BunckeHJ . Blood loss associated with anticoagulation in patients with replanted digits. Journal of Hand Surgery1992;17(2):226‐9. ">Furnas 1992</a>; <a href="./references#CD009894-bbs2-0036" title="GaoW . Clexane (enoxaparin) for prevention of vascular insufficiency after digital replantation. Medical Journal of Chinese People's Health2007;19(10):854‐5. ">Gao 2007</a>; <a href="./references#CD009894-bbs2-0056" title="MaedaM , FukuiA , TamaiS , MizumotoS , InadaY . Continuous local intra‐arterial infusion of antithrombotic agents for replantation (comparison with intravenous infusion). British Journal of Plastic Surgery1991;44(7):520‐5. ">Maeda 1991</a>; <a href="./references#CD009894-bbs2-0059" title="NikolisA , TahiriY , St‐SuperyV , HarrisPG , LandesG , LessardL , et al. Intravenous heparin use in digital replantation and revascularization: the Quebec Provincial Replantation program experience. Microsurgery 2011;31(6):421‐7;31(6):421‐7. ">Nikolis 2011</a>; <a href="./references#CD009894-bbs2-0077" title="YangH , MaQL . Clinical application of fasudil in the treatment of replantation of amputated finger. Qilu Pharmaceutical Affairs2008;27(9):562‐3. ">Yang 2008</a>; <a href="./references#CD009894-bbs2-0078" title="YuXM , LINRS , PengHH . Clinical observation of lidocaine, heparin and dexamethasone in preventing vascular insufficiency after digital replantation (author's translation). Modern Practical Medicine2012;24(4):458‐60. ">Yu 2012</a>; <a href="./references#CD009894-bbs2-0079" title="ZhangHY , LiR , PuXH . Clinical observation of low molecular weight heparin's effect of preventing thrombosis after digital replantation. Chinese Journal of Laboratory Diagnosis2002;6(4):239‐40. ">Zhang 2002</a>; <a href="./references#CD009894-bbs2-0080" title="ZhangC , FengGP , ChengB , SunQ . Application of low molecular weight heparin in atypical digital replantation (author's translation). Chinese Journal of Postgraduates of Medicine2004;5:50‐1. ">Zhang 2004</a>); prospective cohort studies (<a href="./references#CD009894-bbs2-0054" title="LoiselF , PauchotJ , GasseN , MeresseT , RochetS , TropetY , et al. Addition of antithrombosis in situ in the case of digital replantation: preliminary prospective study of 13 cases. Chirurgie de la Main2010;29(5):326‐31. ">Loisel 2010</a>); or animal studies (<a href="./references#CD009894-bbs2-0067" title="RooksMD , RodriguezJJ , BlechnerM , ZusmanisK , HuttonW . Comparative study of intraarterial and intravenous anticoagulants in microvascular anastomoses. Microsurgery1994;15(2):123‐9. ">Rooks 1994</a>). Most of these studies compared anticoagulants other than LMWH, and many of the authors included major limb replantation or free flap transfer in their studies (<a href="./references#CD009894-bbs2-0017" title="AskariM , FisherC , WenigerFG , BidicS , LeeWP . Anticoagulation therapy in microsurgery: a review. Journal of Hand Surgery2006;31(5):836‐46. ">Askari 2006</a>; <a href="./references#CD009894-bbs2-0019" title="AzolovVV , LadyginMS . Comparative characteristics of the effect of drugs on the microcirculation in reconstructive operations on the hand. Ortopediia Travmatologiia I Protezirovanie1983;6:47‐8. ">Azolov 1983</a>; <a href="./references#CD009894-bbs2-0033" title="FukuiA , TamaiS . Present status of replantation in Japan. Microsurgery1994;15(12):842‐7. ">Fukui 1994</a>; <a href="./references#CD009894-bbs2-0048" title="KhouriRK , CooleyBC , KunselmanAR , LandisJR , YeramianP , IngramD , et al. A prospective study of microvascular free‐flap surgery and outcome. Plastic Reconstructive Surgery1998;102(3):711‐21. ">Khouri 1998</a>; <a href="./references#CD009894-bbs2-0056" title="MaedaM , FukuiA , TamaiS , MizumotoS , InadaY . Continuous local intra‐arterial infusion of antithrombotic agents for replantation (comparison with intravenous infusion). British Journal of Plastic Surgery1991;44(7):520‐5. ">Maeda 1991</a>; <a href="./references#CD009894-bbs2-0063" title="PedersonWC . Clinical use of anticoagulants following free tissue transfer surgery. Journal of Hand Surgery2008;33(8):1435‐6. ">Pederson 2008</a>). One RCT compared UFH with no treatment (<a href="./references#CD009894-bbs2-0014" title="ShuT , LiSZ , MiaoZ . The efficacy and risk of intravenous heparin injection in digital replantation. Journal of Guangxi Medical University2011;28(5):731‐3. ">Shu 2011</a>). In this trial, 24 patients with 42 digital replantations were randomised to the UFH group (50 IU/kg IV bolus) versus 25 patients with 35 digital replantations randomised to the control group. The results showed that single‐dose UFH had no positive effect on microvascular patency or success rate of replantation. It is worth noting that 85.7% of the amputations (36/42 in the UFH group and 30/35 in the control group) were incomplete, and 72.7% (30/42 and 26/35, respectively) of the injury mechanisms were crushing and avulsion. To date, no other systematically reviewed evidence concerning LMWH and digital replantation can be found. </p> <p>The efficacy of antithrombotic agents for preventing thrombosis had been reviewed systematically for patients who received infrainguinal arterial bypass surgery (<a href="./references#CD009894-bbs2-0037" title="GeraghtyAJ , WelchK . Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database of Systematic Reviews2011, Issue 6. [DOI: 10.1002/14651858.CD000536.pub2] ">Geraghty 2011</a>). Three of the included trials compared LMWH to UFH and did not show a difference in patency (<a href="./references#CD009894-bbs2-0061" title="NorgrenL , Swedish EnoxaVasc Study Group. Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trial. Journal of Vascular Surgery2004;39(5):977‐84. ">Norgren 2004</a>; <a href="./references#CD009894-bbs2-0068" title="SamamaCM . Low molecular weight heparin (enoxaparin) versus unfractionated heparin during and after arterial reconstructive surgery; a multicenter randomized study. Thrombosis and Haemostasis1994;69(6):546 (abstract 24). ">Samama 1994</a>; <a href="./references#CD009894-bbs2-0071" title="SwedenborgJ , NydahlS , EgbergN . Low molecular mass heparin instead of unfractionated heparin during infrainguinal bypass surgery. European Journal of Vascular and Endovascular Surgery1996;11(1):59‐64. ">Swedenborg 1996</a>). One of the included trials compared LMWH with placebo, in a population receiving aspirin, and found no improvement in graft patency over the first postoperative year (<a href="./references#CD009894-bbs2-0046" title="JivegardL , DrottC , GelinJ , GrothO , HensaterM , JensenN , et al. Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia ‐ a randomised placebo‐controlled double blind multicenter trial. European Journal of Vascular and Endovascular Surgery2005;29(2):190‐8. ">Jivegard 2005</a>). One trial showed an advantage for LMWH versus aspirin and dipyridamol at one year for patients undergoing operations for limb salvage (<a href="./references#CD009894-bbs2-0029" title="EdmondsonRA , CohenAT , DasSK , WagnerMB , KakkarVV . Low molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet1994;344(8927):914‐8. ">Edmondson 1994</a>).The efficacy of LMWH in maintaining the patency of large‐sized vessels is consistent with the findings from our review, when treating much smaller sized vessels such as digital arteries and veins.‐ </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009894-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/urn:x-wiley:14651858:media:CD009894:CD009894-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_t/tCD009894-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009894-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009894-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/urn:x-wiley:14651858:media:CD009894:CD009894-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_t/tCD009894-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009894-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009894-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/urn:x-wiley:14651858:media:CD009894:CD009894-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_t/tCD009894-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009894-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009894-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/urn:x-wiley:14651858:media:CD009894:CD009894-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_t/tCD009894-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 LMWH versus UFH, Outcome 1 Success rate of replantation." data-id="CD009894-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 LMWH versus UFH, Outcome 1 Success rate of replantation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#CD009894-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009894-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/urn:x-wiley:14651858:media:CD009894:CD009894-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_t/tCD009894-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 LMWH versus UFH, Outcome 2 Microvascular insufficiency due to vessel occlusion." data-id="CD009894-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 LMWH versus UFH, Outcome 2 Microvascular insufficiency due to vessel occlusion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#CD009894-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009894-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/urn:x-wiley:14651858:media:CD009894:CD009894-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_t/tCD009894-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 LMWH versus UFH, Outcome 3 Complications and adverse reactions." data-id="CD009894-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 LMWH versus UFH, Outcome 3 Complications and adverse reactions.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#CD009894-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009894-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/urn:x-wiley:14651858:media:CD009894:CD009894-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_t/tCD009894-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus no‐LMWH, Outcome 1 Success rate of replantation." data-id="CD009894-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus no‐LMWH, Outcome 1 Success rate of replantation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#CD009894-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009894-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/urn:x-wiley:14651858:media:CD009894:CD009894-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_t/tCD009894-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus no‐LMWH, Outcome 2 Incidence of compromised microcirculation requiring invasive intervention." data-id="CD009894-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus no‐LMWH, Outcome 2 Incidence of compromised microcirculation requiring invasive intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#CD009894-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009894-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/urn:x-wiley:14651858:media:CD009894:CD009894-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_t/tCD009894-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus no‐LMWH, Outcome 3 Microvascular insufficiency due to vessel occlusion." data-id="CD009894-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus no‐LMWH, Outcome 3 Microvascular insufficiency due to vessel occlusion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#CD009894-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/media/CDSR/CD009894/image_n/nCD009894-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009894-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Low molecular weight heparin versus unfractionated heparin for prevention of microvascular occlusion in digital replantation</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>LMWH versus UFH for prevention of microvascular occlusion in digital replantation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients undergoing digital replantation after traumatic amputation<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> LMWH<br/> <b>Comparison:</b> UFH </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with UFH</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with LMWH</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Success rate of replantation</b><sup>1</sup> </p> <p>(analysed by participant, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.98<br/> (0.87 to 1.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>130<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>910 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>892 per 1000<br/> (792 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Success rate of replantation</b><sup>1</sup> </p> <p>(analysed by digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/> (0.90 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>950 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>922 per 1000<br/> (855 to 989) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of compromised microcirculation requiring invasive intervention (re‐exploration</b>) </p> <p>(analysed by participant/digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>, <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> or <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Incidence of compromised microcirculation requiring invasive intervention (incision)</b> </p> <p>(analysed by participant/digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>, <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a> or <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Microvascular insufficiency due to vessel occlusion ‐ arterial occlusion</b> </p> <p>(analysed by participant/digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.08<br/> (0.16 to 7.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>54<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>77 per 1000<br/> (11 to 507) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Microvascular insufficiency due to vessel occlusion ‐ venous occlusion</b> </p> <p>(analysed by participant, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.81<br/> (0.20 to 3.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>54<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>116 per 1000<br/> (26 to 522) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Complication and adverse reactions ‐ wound bleeding</b> </p> <p>(analysed by participant, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.53<br/> (0.23 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>130<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000<br/> (48 to 257) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>LMWH</b> : low molecular weight heparin; <b>RR:</b> risk ratio; <b>UFH</b>: unfractionated heparin </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Success rate of replantation was study‐based on physician judgement, with no exact definition.<br/> <sup>2</sup> Follow‐up is defined as unclear as there were no available data about duration to follow‐up in <a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a> and <a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>. <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a> mentioned follow up at 14 days post surgery.<br/> <sup>3</sup> We downgraded the level of certainty of evidence from high to very low based on the following reasons: there was a high risk of performance bias and reporting bias; and only two trials with small numbers of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>).<br/> <sup>4</sup> We downgraded the level of certainty of evidence from high to low based on the following reasons: there was a high risk of performance bias; and only two trials with small numbers of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0003" title="LiJX , LiCH , SongHJ . The application of low molecular heparin and heparin after digital replantations (author's translation). Chinese Community Doctors2012;8:205‐6. ">Li 2012a</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>).<br/> <sup>5</sup> We downgraded the level of certainty of evidence from high to very low based on the following reasons: there was a high risk of performance bias and reporting bias; and only one trial with a small number of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>).<br/> <sup>6</sup> We downgraded the level of certainty of evidence from high to low based on the following reasons: there was a high risk of performance bias; and only two trials with small numbers of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0001" title="ChenP , ZhangGH , ZhangXK . The Livaracine digital replantation. Anhui Medical2001;22(5):53‐4. ">Chen 2001</a>; <a href="./references#CD009894-bbs2-0004" title="XuGO , ZhangJH . Efficacy between heparin and low molecular weight heparin after finger replantation. Seek Medical and Ask the Medicine2013;11(10):327‐8. ">Xu 2013</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Low molecular weight heparin versus unfractionated heparin for prevention of microvascular occlusion in digital replantation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009894-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Low molecular weight heparin (LMWH) versus no LMWH for prevention of microvascular occlusion in digital replantation</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>LMWH versus no LMWH for prevention of microvascular occlusion in digital replantation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients undergoing digital replantation after traumatic amputation<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> LMWH<br/> <b>Comparison:</b> control (no LMWH) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control (no LMWH)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with LMWH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Success rate of replantation</b><sup>1</sup> </p> <p>(analysed by participant)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Success rate of replantation</b><sup>1</sup> </p> <p>(analysed by digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.11<br/> (0.93 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>821 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>911 per 1000<br/> (763 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Incidence of compromised microcirculation requiring invasive intervention (re‐exploration)</b> </p> <p>(analysed by digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/> (0.21 to 3.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>88 per 1000<br/> (22 to 367) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Incidence of compromised microcirculation requiring invasive intervention (incision)</b> </p> <p>(analysed by digit, follow‐up unclear<sup>3</sup>) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.72<br/> (0.26 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>73<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>205 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>148 per 1000<br/> (53 to 406) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Microvascular insufficiency due to vessel occlusion ‐ arterial occlusion</b> </p> <p>(analysed by digit, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/> (0.21 to 2.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>118 per 1000<br/> (38 to 368) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Microvascular insufficiency due to vessel occlusion ‐ venous occlusion</b> </p> <p>(analysed by digit, follow‐up 7 day post surgery<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.72<br/> (0.26 to 1.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>205 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>148 per 1000<br/> (53 to 406) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Complication and adverse reactions ‐ wound bleeding</b> </p> <p>(analysed by participant, follow‐up unclear<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>LMWH:</b> low molecular weight heparin; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The success rate of replantation in <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a> was study‐based on physician judgement, with no exact definition.<br/> <sup>2</sup> Follow‐up is judged as unclear as there were no available data on duration to follow‐up in <a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>.<br/> <sup>3</sup> We downgraded the level of certainty of evidence from high to very low based on the following reasons: there was a high risk of performance and reporting bias; and only one trial with a small number of participants provided detailed data for this comparison (<a href="./references#CD009894-bbs2-0002" title="HuRM . The application of low molecular weight heparin after digital replantation. The Medical Forum2013;17:2275. ">Hu 2013</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Low molecular weight heparin (LMWH) versus no LMWH for prevention of microvascular occlusion in digital replantation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009894-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Coagulability measures in the Chen 2001 trial</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Coagulability measures</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Before treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>After LMWH treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>After UFH treatment</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Antithrombin activity</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.97</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.56</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Factor X<sub>a</sub> activity</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.58</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bleeding time</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 minutes 24 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 minutes 18 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 minutes 35 seconds</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clotting time</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 minutes 55 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 minutes 20 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 minutes 32 seconds</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>aPTT</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 seconds</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 seconds</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FDP concentration test</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.6 mg/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3 mg/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.8 mg/L</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>aPTT: activated partial thromboplastin time<br/> FDP: fibrinogen degradation product<br/> LMWH: low molecular weight heparin<br/> UFH: unfractionated heparin </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Coagulability measures in the Chen 2001 trial</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/full#CD009894-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009894-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">LMWH versus UFH</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Success rate of replantation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Unit of analysis: numbers of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.87, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Unit of analysis: numbers of digits</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.90, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Microvascular insufficiency due to vessel occlusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Arterial occlusion (participants)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Venous occlusion (participants)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Complications and adverse reactions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Wound bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.23, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Haematuria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.09, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Gingival bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.02, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Faecal occult blood</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.03, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Epistaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.03, 2.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Ecchymosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.21, 3.19]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">LMWH versus UFH</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#CD009894-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009894-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">LMWH versus no‐LMWH</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Success rate of replantation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Unit of analysis: numbers of digits</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Incidence of compromised microcirculation requiring invasive intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.33, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Re‐exploration (digits)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.21, 3.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Incision (digits)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.26, 1.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Microvascular insufficiency due to vessel occlusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Arterial occlusion (digits)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Venous occlusion (digits)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">LMWH versus no‐LMWH</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009894.pub3/references#CD009894-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009894.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009894-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009894-note-0001">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009894-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD009894-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009894-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009894\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009894\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009894\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009894\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009894\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009894.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009894.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009894.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009894.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009894.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728222860"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009894.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728222864"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009894.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ebf2d8a43f46e',t:'MTc0MDcyODIyMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 